Berenberg raised its target after Lilly's third-quarter results beat expectations and the company raised its 2026 outlook. The target is an analyst estimate, but the company updates point to a stronger business outlook.
The quarter beat expectations, and Lilly raised its own forecast for 2026. Those company updates support a stronger business outlook. Berenberg's target is an analyst estimate, not a promised result.
Follow Eli Lilly and Company (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LLY